A minus 2.5% work RVU efficiency adjustment also applies to established codes like 96372, which slightly reduces the work RVU component used in the payment calculation
What's the clinical reason semaglutide is dosed weekly instead of every 5 days
Using published semaglutide RWE to calibrate plausible parameter ranges, 1,2,9 we illustrate how identical outcomes (12% weight loss at 9 months) can yield materially different drug-attributable shares across patient scenarios
That is why our Doral clinic prescribes CJC-1295/Ipamorelin and does not offer Sermorelin
The pancreatic effects of GLP-1 receptor activation in humans appear to be complex and likely influenced by individual patient factors, pre-existing pancreatic health, and concurrent metabolic conditions

Other Popular Peptides in the Gray Zone: Thymosin Alpha-1 Immune support (approved in 35+ countries, NOT in US) GHK-Cu (Copper Peptide) Skin/hair (injectable form banned by FDA) Epitalon Claimed anti-aging (no human studies) LL-37 Antimicrobial (research only) AOD-9604 Fat loss (FDA banned) Semorelin Growth hormone release Melanotan II Tanning (serious side effects) The FDA Crackdown: What Happened in Late 2023 Timeline of the Ban: 2023: FDA adds 12+ peptides to "Category 2 Bulk Drug Substances" list What this means: Compounding pharmacies CANNOT legally make these peptides FDA cites "significant safety risks" No approved use in humans Peptides specifically banned from compounding: BPC-157 TB-500 (Thymosin Beta-4 fragment) Thymosin Alpha-1 CJC-1295 Ipamorelin AOD-9604 GHK-Cu (injectable) Epitalon LL-37 DSIP KPV Selank Semax And more